Kanes Stephen 4
4 · Sage Therapeutics, Inc. · Filed Dec 11, 2018
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-12-07+6,600→ 6,600 totalExercise: $47.70Exp: 2027-02-06→ Common Stock (6,600 underlying)
Footnotes (1)
- [F1]On February 6, 2017, the reporting person was granted an option to purchase 20,000 shares of common stock. The option vests upon the achievement of certain milestones, one of which was met on December 7, 2018, resulting in the vesting of the option as to 6,600 shares.